The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning.

NBC/KARE 11 News: Eye Exam to Detect Alzheimer's

Center for Drug Design (College of Pharmacy, University of Minnesota) has signed an agreement to collaborate with medical imaging startup RetiSpec to commercialize the technology for early detection of Alzheimer’s disease.

Robert Vince PhD, inventor of the AIDS drug Ziagen and one of the University of Minnesota's most prolific researchers, was honored at the National Academy of Inventors (NAI) 2018 Annual Conference as an NAI Fellow

Compounds developed in Robert Vince’s University of Minnesota lab to combat the HIV virus made the University more than $600 million dollars.

The Twin Cities Business Magazine discusses the cyanide antidote invented by Profs. Vince, Patterson, and Nagasawa. The USPTO has issued a new patent to the U of M Regents on September 12, 2017. 

Prof Swati More, and Prof Robert Vince (Director of the Center for Drug Design), have discovered a potential new drug that works as an antidote to acetaminophen poisoning.

Prof Robert Vince has been awarded the Antonin Holy Memorial Award from the International Society for Antiviral Research (ISAR)

On Dec. 11, 2014, Bob Vince won the Impact Award for his development of the ground-breaking AIDS drug, Ziagen.